The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.

The FDA has approved sotorasib with panitumumab for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC) ...

The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...

Improved education on drug toxicity management, especially within the first 90 days of treatment and regarding individualized ...

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

Sasanlimab (PF-06801591) added to BCG therapy significantly improved outcomes for patients with BCG-naive, high-risk ...

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...

Video content above is prompted by the following: Please present slides with patient case details and moderate brief discussion.

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...